Companies /Healthcare

Pelthos Therapeutics Inc.

NYSE MKT: PTHS Biotechnology
$24.73
▼ $0.27 (−1.08%) today
Markets closed · 1:43am ET
Today · % change

Fundamentals

Market Cap
$95.7M
Profit Margin
-199.5%
Revenue (TTM)
$43.3M
EPS (TTM)
$-28.63
52-Week Range
$18 – $38
Street Target
$53.14

About Pelthos Therapeutics

Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company is headquartered in Durham, North Carolina.

PTHS Coverage